13.07.2015 Views

Full text PDF - International Policy Network

Full text PDF - International Policy Network

Full text PDF - International Policy Network

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

242 Fighting the Diseases of Povertyare subsequently enforced. Hence, the pace of health-relatedresearch within a market economy depends on how successfullygovernment discharges its background presence.The difference between government in the background and inthe foreground is extremely important. The world may be a stage,as Jacques asserts in As You Like It, but market participants populatethe foreground while political officials remain in the background.That background entails essential work, for the play cannot goforward without the work of the stagehands. But it is backgroundwork nonetheless, out of the public’s sight.The foreground is occupied by those market participants (firms,entrepreneurs, customers, consumers) who establish hospitals andpharmaceutical companies, as well as the myriad other enterprisesand transactions, which contribute to the generation of healthrelatedenterprises and outcomes within a market economy. In thebackground, government facilitates commerce between these participantsby protecting relationships established through the principlesof property and contract.Two categories of activity, conveyed by smallpox (to representcommunicable diseases) and Mother Teresa (to represent charitytowards the poor), might provide a justification for governmentagencies to move out of the background and into the foreground.In dealing with communicable diseases, the presumption ofmarket efficiency that generally obtains for non-communicablediseases becomes questionable. It is a truism to say that people willbuy protection against diseases to the extent that they perceivesuch protection to be worthwhile. For non-communicable diseases,this creates a situation where people will rely on market-generatedoptions to secure protection, so long as the cost of securing additionalprotection is less than the benefit they believe that additionalprotection will provide. In this benefit-cost sense, market-basedoutcomes with respect to health generate efficient levels of protectionagainst non-communicable diseases.However, the situation does not necessarily apply to communicablediseases. Someone who acquires a communicable disease

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!